FACT overexpression in multiple tumor types (e.g., non-small-cell lung cancer (NSCLC), pancreatic cancer, breast cancer, and neuroblastoma) correlates with poor prognosis [30,31,32]. This evidence concerns the gene SSRP1 and non-small cell lung carcinoma.